These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2143575)

  • 1. [Evaluation of the socio-economic effect of using immune anti- meningococcal plasma in pediatric practice].
    Smirnova AI; Kochetygina AA; Nikolaeva LK; Zinchenko AP; Sorokina MN; Romanchenko TG
    Pediatriia; 1990; (3):36-9. PubMed ID: 2143575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimeningococcal plasma in the combined treatment of meningococcal infection in children].
    Sorokina MN; Dadiomova MA; Zinchenko AP; Smirnova AI; Korzhueva NA
    Pediatriia; 1988; (2):80-4. PubMed ID: 3131732
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of industrially produced diagnostic meningococcal agglutinating sera].
    Trushnikova AG
    Lab Delo; 1985; (5):302-4. PubMed ID: 2409341
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of the methods of monitoring the activity of diagnostic meningococcal group-specific sera].
    Ereshchenko VV; Petrova ZS; Zhukova LF
    Lab Delo; 1982; (9):567-9. PubMed ID: 6183530
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Meningococcal Disease.
    Nadel S
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S21-8. PubMed ID: 27449146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice.
    Zarantonelli ML; Antignac A; Lancellotti M; Guiyoule A; Alonso JM; Taha MK
    J Antimicrob Chemother; 2006 May; 57(5):924-30. PubMed ID: 16513914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody response in subjects with meningococal disease and in healthy carriers of Neisseria meningitidis].
    Natoli D; Tringali G; Puma G; Castellini S; Chiarini A
    G Batteriol Virol Immunol; 1976; 69(1-6):64-70. PubMed ID: 828887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
    Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
    J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute meningococcaemia with chemotherapy and immune plasma.
    Taqi AM; Macfarlane JT; Morton R; Wali SS; Greenwood BM
    J Infect; 1980 Jun; 2(2):145-9. PubMed ID: 6193201
    [No Abstract]   [Full Text] [Related]  

  • 12. [Invasive meningococcal disease].
    Sokołowski R; Targowski T
    Pol Merkur Lekarski; 2012 Nov; 33(197):255-60. PubMed ID: 23394035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
    Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
    Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Method of obtaining meningococcal agglutinating serum of high titre and its use in the indirect immunofluorescence test].
    Okropiridze GG; Pavlov GA; Mal'tseva AN; Akopiants EIa; Balashova RR
    Lab Delo; 1977; (8):489-91. PubMed ID: 72859
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccines for the poor: meningococcal A conjugate vaccine in Africa.
    Isaacs D
    J Paediatr Child Health; 2011 Jan; 47(1-2):66. PubMed ID: 21255149
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic meningococcal sera and their quality].
    Andreeva ZM; Kovaleva VV; Filimonova IN
    Lab Delo; 1989; (5):74-6. PubMed ID: 2473272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Ceccherini V; Taddei C; Balocchini E; Bonanni P
    J Prev Med Hyg; 2012 Jun; 53(2):61-7. PubMed ID: 23240162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
    Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
    Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological study of meningococcus b in an open environment and prevention of cerebrospinal meninitis (apropos of 450 rhino-pharyngeal specimens and 95 anti-meningococcal sera)].
    Fourrier A; Anquez E; Mouton Y; Caillaux M; Socolovsky C; Beaucaire G; Dracon M
    Lille Med; 1977 May; 22(5):296-302. PubMed ID: 408574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.